Canada · Delayed Price · Currency is CAD Pharmala Biotech Holdings Statistics
Total Valuation
CSE:MDMA has a market cap or net worth of CAD 15.29 million. The enterprise value is 15.04 million.
| Market Cap | 15.29M |
| Enterprise Value | 15.04M |
Important Dates
The next estimated earnings date is Thursday, December 24, 2026.
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:MDMA has 109.24 million shares outstanding. The number of shares has increased by 8.69% in one year.
| Current Share Class | 109.24M |
| Shares Outstanding | 109.24M |
| Shares Change (YoY) | +8.69% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 9.27% |
| Owned by Institutions (%) | n/a |
| Float | 98.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.06 |
| PB Ratio | 7.92 |
| P/TBV Ratio | 78.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
| Current Ratio | 1.17 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.66% and return on invested capital (ROIC) is -37.90%.
| Return on Equity (ROE) | -68.66% |
| Return on Assets (ROA) | -26.50% |
| Return on Invested Capital (ROIC) | -37.90% |
| Return on Capital Employed (ROCE) | -73.61% |
| Weighted Average Cost of Capital (WACC) | 8.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.41% in the last 52 weeks. The beta is 0.75, so CSE:MDMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +7.41% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 47.40 |
| Average Volume (20 Days) | 94,509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:MDMA had revenue of CAD 1.27 million and -1.61 million in losses. Loss per share was -0.02.
| Revenue | 1.27M |
| Gross Profit | 1.00M |
| Operating Income | -1.42M |
| Pretax Income | -1.61M |
| Net Income | -1.61M |
| EBITDA | -1.41M |
| EBIT | -1.42M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 249,143 in cash and no debt, with a net cash position of 249,143 or 0.00 per share.
| Cash & Cash Equivalents | 249,143 |
| Total Debt | n/a |
| Net Cash | 249,143 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.93M |
| Book Value Per Share | 0.02 |
| Working Capital | 193,023 |
Cash Flow
In the last 12 months, operating cash flow was -968,527 and capital expenditures -2,918, giving a free cash flow of -971,445.
| Operating Cash Flow | -968,527 |
| Capital Expenditures | -2,918 |
| Depreciation & Amortization | 6,360 |
| Net Borrowing | n/a |
| Free Cash Flow | -971,445 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 79.02%, with operating and profit margins of -112.07% and -126.87%.
| Gross Margin | 79.02% |
| Operating Margin | -112.07% |
| Pretax Margin | -126.87% |
| Profit Margin | -126.87% |
| EBITDA Margin | -111.57% |
| EBIT Margin | -112.07% |
| FCF Margin | n/a |
Dividends & Yields
CSE:MDMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.69% |
| Shareholder Yield | -8.69% |
| Earnings Yield | -10.52% |
| FCF Yield | -6.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:MDMA has an Altman Z-Score of 1.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.64 |
| Piotroski F-Score | 2 |